| 국소적 식도암에서 선행 화학요법과 방사선 병행치료후 수술을 하는 복합치료의 효과 - 중간 보고 - |
| 장윤혜, 김성배, 김상희, 최종수, 장대영, 이제환, 김상위, 서철원, 이규형, 이정신, 김우건, 송호영, 장혜숙, 김종훈 |
|
| Effects of Concurrent Chemoradiotherapy Followed by Surgery in Locoreginal Cancer - preliminary report - |
| Yun Hae Chang, Sung Bae Kim, Sang Hee Kim, Jong SU Choi, Dae Young Chang, Je Whan Lee, Sang We Kim, Cheolwon Suh, Kyon Hung Lee, Jung Shin Lee, Woo Gyun Kim, Ho Young Song, Hye Sook Chang, Hong Hoon K |
|
|
|
|
|
|
|
| ABSTRACT |
|
Prognosis of locoregional esophageal cancer treated with conventional surgery or radiotherapy alone has been very poor. In order to improve outcome and determine the efficacy of a combined modality therapy, this prospective study was performed. Between May 1993 and April l995, 44 patients with locoregional esophageal cancer were entered this study. They were treated with 2 courses of 5-FU(DI-5, D30-33) and cisplatin (Dl, D29) plus 48Gy radiation therapy over 4 weeks. 44 patients completed the preoperative reatment. A transhiatal esophagectomy was planned 3~4 weeks after chemoradiotherapy. Clinical response were reevaluable in 43 patients after treatment: 34 patients showed improvement, 5 patients showed stable, 4 patients showed progression. One patient was died of sepsis 1 week after completion of chemotherapy. l8 patients underwent operation after chemoradiation and 9 patients showed complete pathologic response. Grade 3,4 leukopenia and thrombocytopenia were observed in 21% and 7%, respectively. Esophagitis and vomiting were moderate to severe in 43% patients. Median follow-up duration was 7.5months(2-21M), the median survival was not reached. In conclusion, this intensive combined therapy is promising modality with regards to relatively high pathologic complete response rate. Further randomized Jarge scaled study was warrented |
| Key words:
Preoperative chemoradiotherapy, Esophagectomy, Esophageal cancer |
|
PDF Links
Full text via DOI 
Download Citation 
CrossRef TDM
